There are many ongoing clinical trials that leverage the power of the immune system to recognize tumor cells such as CD47 and PDL1/PD1, and even engineered T cells!

I ran across an immune cell type for the first time during graduate school applications while browsing faculty research interests. I have been researching cancer for 19 years. The cells, myeloid-derived suppressor cells (MDSCs), are considered a regulatory immune cell distinct from the well known T regulatory cells (Tregs). An an immune regulator cell, MDSCs increase interleukin 10 activity. MDSCs appear to have been researched for more than a decade.

Are there any clinical derivatives from MDSC research, i.e., clinical trials for cancer or vaccines to foreign antigens?

Your Answer

By clicking “Post Your Answer”, you agree to our terms of service, privacy policy and cookie policy

Browse other questions tagged or ask your own question.